Heavy smoking and liver
Open Access
- 1 January 2006
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (38) , 6098-6101
- https://doi.org/10.3748/wjg.v12.i38.6098
Abstract
Smoking causes a variety of adverse effects on organs that have no direct contact with the smoke itself such as the liver. It induces three major adverse effects on the liver: direct or indirect toxic effects, immunological effects and oncogenic effects. Smoking yields chemical substances with cytotoxic potential which increase necroinflammation and fibrosis. In addition, smoking increases the production of pro-inflammatory cytokines (IL-1, IL-6 and TNF-α) that would be involved in liver cell injury. It contributes to the development of secondary polycythemia and in turn to increased red cell mass and turnover which might be a contributing factor to secondary iron overload disease promoting oxidative stress of hepatocytes. Increased red cell mass and turnover are associated with increased purine catabolism which promotes excessive production of uric acid. Smoking affects both cell-mediated and humoral immune responses by blocking lymphocyte proliferation and inducing apoptosis of lymphocytes. Smoking also increases serum and hepatic iron which induce oxidative stress and lipid peroxidation that lead to activation of stellate cells and development of fibrosis. Smoking yields chemicals with oncogenic potential that increase the risk of hepatocellular carcinoma (HCC) in patients with viral hepatitis and are independent of viral infection as well. Tobacco smoking has been associated with supression of p53 (tumour suppressor gene). In addition, smoking causes suppression of T-cell responses and is associated with decreased surveillance for tumour cells. Moreover, it has been reported that heavy smoking affects the sustained virological response to interferon (IFN) therapy in hepatitis C patients which can be improved by repeated phlebotomy. Smoker’ssyndrome is a clinico-pathological condition where patients complain of episodes of facial flushing, warmth of the palms and soles of feet, throbbing headache, fullness in the head, dizziness, lethargy, prickling sensation, pruritus and arthralgia.Keywords
This publication has 38 references indexed in Scilit:
- Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 2005
- Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinomaJournal of Hepatology, 2004
- Smoking and liver cancer in China: Case‐control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deathsInternational Journal of Cancer, 2003
- Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trialHepatology, 2000
- A P53 Genetic Polymorphism As A Modulator of Hepatocellular Carcinoma Risk in Relation to Chronic Liver Disease, Familial Tendency, and Cigarette Smoking in Hepatitis B CarriersHepatology, 1999
- Effects of Cigarette Smoking on Fas/Fas Ligand Expression of Human LymphocytesCellular Immunology, 1999
- Vitamin C supplementation on hepatic oxidative stress induced by cigarette smokeJournal of Applied Toxicology, 1997
- The Effect of Nicotine and Its Interaction with Carbon Tetrachloride in the Rat LiverBasic & Clinical Pharmacology & Toxicology, 1995
- Smoke inhalation: Diagnosis and treatmentJournal of Clinical Anesthesia, 1989
- Inhalation injuriesAnnals of Emergency Medicine, 1988